Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KNC Laboratories CoFRA:7LW +0.17%81 EV-to-EBIT is 9.10 as of Sep. 02, 2026, which is 16% below its 10-year median of 10.88. GuruFocus rates FRA:7LW with a GF Score™ of 81/100 and a GF Value™ of €6.29. The stock has 5 warning signs investors should review. Among 1,275 Chemicals companies, KNC Laboratories Co ranks better than 74.12% on this metric.
KNC Laboratories Co (FRA:7LW) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
KNC Laboratories Co's Enterprise Value for the quarter that ended in Mar. 2026 was €0.00 Mil.
KNC Laboratories Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €6.22 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KNC Laboratories Co EV-to-EBIT Related Terms
KNC Laboratories Co EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for KNC Laboratories Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, KNC Laboratories Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KNC Laboratories Co EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, KNC Laboratories Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where KNC Laboratories Co's EV-to-EBIT falls into.
KNC Laboratories Co's current Enterprise Value is €56.60 Mil.
KNC Laboratories Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €6.22 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KNC Laboratories Co (FRA:7LW) has a EV-to-EBIT of 9.10 as of Sep. 02, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on KNC Laboratories Co and its competitors. This is 16% below median its historical median of 10.88. Over the past decade, KNC Laboratories Co's EV-to-EBIT has ranged from 4.06 to 335.56. According to the industry distribution chart, KNC Laboratories Co ranks #330 out of 1275 companies in the Chemicals industry, placing it in the top 25.9%.
Is KNC Laboratories Co's EV-to-EBIT too high?
KNC Laboratories Co's current EV-to-EBIT of 9.10 is 16% below median its 10-year median of 10.88. Over the past 10 years, this metric has ranged from a low of 4.06 to a high of 335.56. The Chemicals industry median EV-to-EBIT is 16.85. KNC Laboratories Co's value of 9.10 is 46% below this industry median. Based on the distribution chart, KNC Laboratories Co ranks #330 out of 1275 companies in the Chemicals industry, which is above the industry midpoint. Overall, KNC Laboratories Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does KNC Laboratories Co's EV-to-EBIT compare to DOW?
According to the Chemicals industry distribution chart, KNC Laboratories Co ranks #330 out of 1275 companies for EV-to-EBIT. This puts KNC Laboratories Co in the upper half of its industry. The industry median EV-to-EBIT is 16.85. KNC Laboratories Co's value of 9.10 is 46% below this benchmark. Historically, KNC Laboratories Co's own EV-to-EBIT has ranged from 4.06 to 335.56 over the past decade. While the company's 10-year median is 10.88 vs. the industry median of 16.85, KNC Laboratories Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 16.85, based on 1,275 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KNC Laboratories Co's current EV-to-EBIT of 9.10 is 46% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on KNC Laboratories Co and its competitors. For the Chemicals industry, the median EV-to-EBIT is 16.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KNC Laboratories Co's current EV-to-EBIT is 9.10, which is 16% below median its own 10-year median of 10.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KNC Laboratories Co stock overvalued right now?
KNC Laboratories Co (FRA:7LW) has a current EV-to-EBIT of 9.10. The stock's GF Value™ is €6.29, compared to a current price of €6.05 — trading 3.8% below its estimated fair value. The current EV-to-EBIT is 9.10, which is 16% below median its 10-year median of 10.88 and 46% below the Chemicals industry median of 16.85. KNC Laboratories Co's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For KNC Laboratories Co (FRA:7LW), the current EV-to-EBIT is 9.10 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KNC Laboratories Co (FRA:7LW) Overvalued in 2026?
Based on GuruFocus' analysis, KNC Laboratories Co stock appears to be undervalued.
The current stock price of €6.05 is trading 3.8% below its estimated GF Value™ of €6.29.
Key valuation signals for FRA:7LW:
EV-to-EBIT: 9.10 (16% below median its 10-year median of 10.88)
GF Value™: €6.29 vs. price of €6.05 (3.8% below fair value)
Industry Position: 46% below the Chemicals median (#330 of 1275)
No single metric tells the full story. See the FRA:7LW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7LW has been successfully added to your 
